KRAS Inhibitors Market Size, Share & Industry Analysis, By Drug (Sotorasib, Adagrasib, Divarasib, Olomorasib, RMC-6236, KRAS G12D Inhibitors, and Others), By Disease Indication (Non-Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Cancer, Biliary Tract Cancer, and Others), By Age Group (Pediatric and Adults), By Type (KRAS G12C Inhibitors, KRAS G12D Inhibitors, and Others), By Route of Administration (Oral and Parenteral), By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail & Drug Store Pharmacies, and Online Pharmacies), and Regional Forecast, 2026-2034